Drugs / Fibrogammin P
last change Dec 2011 re-read 3 minutes ago

Fibrogammin P

Protein / enzyme biologic

Developed for
factor XIII deficiency · hemophilia
Investigated by
CSL Behring · Children's Hospital of Orange County

Trials 1

2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00640289 Jan 2000 → Dec 2011 factor XIII deficiency, hemophilia Children's Hospital of Orange County Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Fibrogammin P ClinicalTrials.gov intervention name — accepted as the source's own label NCT00640289 ↗
Modality Protein / enzyme biologic “Factor XIII Concentrate From Human Plasma” NCT00640289 ↗
Route Other “Infusion of Factor XIII” NCT00640289 ↗